Asia Pacific Newborn Screening Market 2018: Executive Summary, Introduction, Market Sizing and Five Forces Analysis up to 2026

Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2546

Market Dynamics

Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.

Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.

Increasing engagement programs by various government healthcare regulatory bodies for newborn screening and its deployment for wider population base are expected to drive growth of the market during the forecast period. For instance, in June 2014, PerkinElmer, a company engaged in the diagnostics, life science research, food, environmental and industrial testing area, entered into an exclusive collaboration with China's National Health and Family Planning Commission (NHFPC) to implement a three-year training program for newborn screening.

The National Maternal & Children Health Surveillance Office (NMCHSO) is working with PerkinElmer, to increase availability and adoption of newborn screening in China, particularly via expansion in more rural areas.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2546

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.